Page last updated: 2024-08-21

ethylnitrosourea and Local Neoplasm Recurrence

ethylnitrosourea has been researched along with Local Neoplasm Recurrence in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alomran, R; Brown, JM; Chernikova, SB; Jang, T; Klussmann, S; Kruschinski, A; Lartey, F; Liu, SC; Merchant, M; Recht, L; Stafford, J; Zboralski, D; Zöllner, S	1
Kwiatkowski, D; Lane, H; Malinowska-Kolodziej, I; Pollizzi, K; Stumm, M	1
Albain, KS; Crowley, JJ; Gandara, D; Griffin, B; Hutchins, L; Livingston, RB; O'Bryan, RM; Von Hoff, DD	1

Trials

1 trial(s) available for ethylnitrosourea and Local Neoplasm Recurrence

Article	Year
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base. Cancer, 1993, Aug-15, Volume: 72, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ethylnitrosourea; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Thiotepa; Vincristine	1993

Article

Year

Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.

Cancer, 1993, Aug-15, Volume: 72, Issue:4

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ethylnitrosourea; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Thiotepa; Vincristine

1993

Other Studies

2 other study(ies) available for ethylnitrosourea and Local Neoplasm Recurrence

Article	Year
Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats. Neuro-oncology, 2014, Volume: 16, Issue:1 Topics: Alkylating Agents; Animals; Brain Neoplasms; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Ethylnitrosourea; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptors, CXCR; Receptors, CXCR4; Survival Rate; X-Ray Therapy	2014
Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis. Molecular cancer, 2009, Jun-15, Volume: 8 Topics: Animals; Antineoplastic Agents; Carrier Proteins; Disease Models, Animal; Ethylnitrosourea; Everolimus; Imidazoles; Kidney Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiprotein Complexes; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Proteins; Quinolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Tuberous Sclerosis	2009

Article

Year

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats.

Neuro-oncology, 2014, Volume: 16, Issue:1

Topics: Alkylating Agents; Animals; Brain Neoplasms; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Ethylnitrosourea; Human Umbilical Vein Endothelial Cells; Humans; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptors, CXCR; Receptors, CXCR4; Survival Rate; X-Ray Therapy

2014

Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis.

Molecular cancer, 2009, Jun-15, Volume: 8

Topics: Animals; Antineoplastic Agents; Carrier Proteins; Disease Models, Animal; Ethylnitrosourea; Everolimus; Imidazoles; Kidney Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mice, Transgenic; Multiprotein Complexes; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Proteins; Quinolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Transcription Factors; Tuberous Sclerosis

2009